Winchester, MA, United States of America

Abhijit S Bhat

This inventor holds 1 USPTO granted patent. Top assignee: Pfizer Corporation. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Abhijit S Bhat. Retrieved from https://idiyas.com/inventor/abhijit-s-bhat

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Biography of Abhijit S Bhat

Introduction

Abhijit S Bhat is an accomplished inventor based in Winchester, MA (US). He has made significant contributions to the field of medical science, particularly in the development of novel cytotoxic compounds.

Latest Patents

He holds a patent for "Tubulysin analogs and methods for their preparation." This invention focuses on innovative cytotoxic tubulysin analogs and derivatives, which can be utilized in antibody drug conjugates. The methods developed aim to treat various medical conditions, including cancer.

Career Highlights

Abhijit S Bhat is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to engage in cutting-edge research and development in the pharmaceutical industry.

Collaborations

Throughout his career, Abhijit has collaborated with notable colleagues, including Chakrapani Subramanyam and Lawrence Nathan Tumey. These collaborations have further enhanced his research and innovation efforts.

Conclusion

Abhijit S Bhat's contributions to the field of medicine through his inventions and collaborations highlight his dedication to advancing healthcare solutions. His work continues to impact the treatment of serious medical conditions, showcasing the importance of innovation in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…